REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-22. Numbers and descriptions here follow the published literature rather than marketing material.
Quality control for research materials includes identity confirmation by nuclear magnetic resonance and purity assessment by high-performance liquid chromatography. Mass spectrometry provides molecular weight confirmation and can detect related impurities. Purchasers should request a certificate of analysis that lists lot-specific data. Online products advertised for human use often lack such documentation. Distinguishing legitimate research material from mislabeled or contaminated samples is a recurring challenge in independent testing, and independent laboratories may use orthogonal methods to verify identity.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated and protected from light |
| Common analytical method | LC-MS/MS | Detects parent drug and metabolites |
| Solubility class | Lipophilic; soluble in organic solvents | Low aqueous solubility |
| Molecular weight | 437.94 g/mol | Calculated from reported formula |
| Synonyms | SR9009; REV-ERB agonist | Code name used in scientific literature |
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
==== Primate research ==== Evidence of gradual expansion of the frontal lobe during the evolutionary history of primates, as well as evidence of rapid expansion of nonfrontal neocortical regions that might have been linked to enhanced visual processing in primates, is presented by Kay et al. (2026). Cartmill & Brown (2026) review the history of the visual-predation theory, and argue that it represents the best available explanation for the origin of primates. A study on the morphology of molar teeth of extant and extinct members of Euarchonta, providing evidence of evolution of morphological changes associated with increased herbivory at the base of Euprimates, is published by Bradley-Cronkwright et al. (2026). Marigó et al. (2026) review new discoveries and main advances in the study of Paleogene primates from Spain from late 2013 to 2025. One of the oldest euprimate petrosal bones reported to date, likely belonging to Marcgodinotius indicus, is described from the Eocene strata from the Vastan Lignite Mine (India) by Silcox et al. (2026). Alfieri et al. (2026) reconstruct the locomotor behavior of Malagasy Quaternary lemurs on the basis of the study of their humeral and femoral trabecular architecture, reporting evidence of suspensory adaptations not only in sloth lemurs, but also in Megaladapis edwardsi. Robinson et al.
== Society and culture == The term was first used in the 14th century. A fistula plays a central role in William Shakespeare's play All's Well That Ends Well. An arteriovenous fistula is also a main plot point in Richard Fleischer's 1966 film Fantastic Voyage (screenplay by Harry Kleiner), sending the miniaturized submarine inside a patient's body on an unforeseen course.
=== Traditional accelerationism === Traditional accelerationism, as developed by the British philosopher Nick Land, sees the acceleration of technological change as a way to bring about a fundamental transformation of current culture, society, and the political economy. This is done through capitalism, which Land views as "an autonomous force that’s reconfiguring society" that can overcome its limits if intensified. Land's work has also been characterized as concerning "the supposedly inevitable 'disintegration of the human species' when artificial intelligence improves sufficiently." While both concern ideas like a technocapital singularity and AGI progress, effective accelerationism focuses on using AGI for the greatest ethical good for conscious life and civilization (whether human or machine), as well as expanding civilization and maximizing energy usage in order to align with the "will of the universe". Land focuses on capitalist self-optimization as the driver of modernity, progress, and the eroding of existing social orders. Land has expressed support for effective accelerationism, while Thomas Murphy referred to the movement as "Nick Land diluted for LinkedIn".
Engrafting an immunodeficient mouse with functional human cells can be achieved by intravenous injections of human cells and tissue into the mouse, and/or creating a genetically modified mouse from human genes. These models have been instrumental in studying human diseases, immune responses, and therapeutic interventions. This section highlights the various humanized mice models developed using the different methods.
Dehydration at 315 °C: 2 NaHSO4 → Na2S2O7 + H2O Cracking at 460 °C: Na2S2O7 → Na2SO4 + SO3 The latter occurs at lower temperatures (around 300 °C) in the presence of catalytic H2SO4. KHSO4 undergoes the same reactions at a higher temperature. Another two step method involving a salt pyrolysis starts with concentrated sulfuric acid and anhydrous tin tetrachloride:
Sources: en.wikipedia.org
== Nomenclature == Alternative names provided by the EC include 3CLpro, 3C-like protease, coronavirus 3C-like protease, Mpro, SARS 3C-like protease, SARS coronavirus 3CL protease, SARS coronavirus main peptidase, SARS coronavirus main protease, SARS-CoV 3CLpro enzyme, SARS-CoV main protease, SARS-CoV Mpro and severe acute respiratory syndrome coronavirus main protease.
During his mayoralty, Sanders called himself a socialist and was described as such in the press. During his first term, his supporters, including the first Citizens Party city councilor Terry Bouricius, formed the Progressive Coalition, the forerunner of the Vermont Progressive Party. The Progressives never held more than six seats on the 13-member city council, but they had enough to keep the council from overriding Sanders's vetoes. Under his leadership, Burlington balanced its city budget; attracted a minor league baseball team, the Vermont Reds, then the Double-A affiliate of the Cincinnati Reds; became the first US city to fund community-trust housing; and successfully sued the local cable television franchise, thereby winning reduced rates for customers. Sanders led downtown revitalization projects, including the improvement of Burlington's Lake Champlain waterfront. In 1981, he campaigned against the unpopular plans by Burlington developer Tony Pomerleau to convert the then-industrial waterfront property owned by the Central Vermont Railway into expensive condominiums, hotels, and offices. He ran under the slogan "Burlington is not for sale" and successfully supported a plan that redeveloped the waterfront area into a mixed-use district featuring housing, parks, and public spaces. Sanders was a consistent critic of US foreign policy in Latin America throughout the 1980s. In 1985, Burlington City Hall hosted a foreign policy speech by Noam Chomsky.
Mahmood T, Yang PC (September 2012). "Western blot: technique, theory, and trouble shooting". North American Journal of Medical Sciences. 4 (9): 429–434. doi:10.4103/1947-2714.100998 (inactive 12 July 2025). PMC 3456489. PMID 23050259.{{cite journal}}: CS1 maint: DOI inactive as of July 2025 (link) Archived at Ghostarchive and the Wayback Machine: "Western Blotting". YouTube. Bio-Rad Laboratories. 16 October 2012. Archived at Ghostarchive and the Wayback Machine: "Blotting Techniques/ The Principle of Western Blotting". YouTube. Biomedical and Biological Sciences. 23 March 2017.
=== Instrument Calibration and Quality Control === All refractive index detectors require calibration upon first setting up the instrument as well as periodic quality control. Most manufacturer's recommend calibration with pure water and a sucrose calibration solution of a known refractive index. Once the instrument is in calibration mode, the pure water acts as a zero baseline reading, while the sucrose solution compares its known RI to the output, and the machine is adjusted accordingly. After the pump has not been used for a while, it is necessary to purge the tubes of any contaminant air that has diffused into the channels. This is typically accomplished with isopropyl alcohol.
Sources: en.wikipedia.org
Liquid chromatography-tandem mass spectrometry is a common approach. It can detect the parent compound and its metabolites in biological matrices.
Research samples are typically kept frozen, desiccated, and protected from light. Stock solutions are often aliquoted to reduce freeze-thaw cycles.
High-performance liquid chromatography and nuclear magnetic resonance are standard for purity and identity. Mass spectrometry confirms molecular weight.
No. It is an investigational compound without approved therapeutic indications. It is sold for research purposes only in many jurisdictions.